On April 24, 2024 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the "Company"), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, reported that clinical data for lifileucel in combination with pembrolizumab in frontline advanced melanoma, as well as translational data, will be highlighted at the upcoming 2024 ASCO (Free ASCO Whitepaper) Annual Meeting to be held May 31- June 4, 2024, at McCormick Place in Chicago, IL and online (Press release, Iovance Biotherapeutics, APR 24, 2024, View Source [SID1234642288]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
ASCO 2024 Highlights for Iovance
Oral Presentation: Efficacy and safety of lifileucel, an autologous tumor-infiltrating lymphocyte cell therapy, and pembrolizumab in patients with immune checkpoint inhibitor-naive unresectable or metastatic melanoma: updated results from IOV-COM-202 Cohort 1A (Abstract 9505)
Session: Melanoma/Skin Cancers, Friday, May 31, 2024, 2:45 – 5:45pm ET
Poster: IOV-3001, a modified interleukin-2 fusion protein, for potential use in tumor-infiltrating lymphocyte cell therapy regimens (Abstract 2552)
Session: Developmental Therapeutic – Immunotherapy, Saturday, June 1, 2024, 9:00 am – 12:00 pm ET
Poster: Dynamics of circulating cytokines and chemokines during and after tumor-infiltrating lymphocyte cell therapy with lifileucel in advanced melanoma patients (Abstract 9594)
Session: Melanoma/Skin Cancers, Saturday, June 1, 2024, 1:30 – 4:30 pm ET
Iovance will host an event on the evening of Friday, May 31, 2024 to summarize the data highlights at ASCO (Free ASCO Whitepaper). The live and archived event webcast will be available in the Investors section of the company’s website at www.iovance.com.